Entero Healthcare Re-appoints Ernst & Young as Internal Auditor

Entero Healthcare Solutions Ltd's Board approved the re-appointment of M/s. Ernst & Young LLP ('EY') as the Internal Auditor for the financial year 2026-27. The board also approved the re-appointment of Mr. Sujesh Vasudevan, Mr. Rajesh Shashikant Dalal, and Ms. Sandhya Gadkari Sharma as Non-Executive Independent Directors for a second term of five years, subject to shareholder approval. Additionally, the board approved the allotment of 7,240 equity shares to eligible employees under the Entero Employee Stock Option Plan 2023 and noted the grant of fresh 7,300 Employee Stock Options.